ASSEMBLY BIOSCIENCES, INC. (ASMB) Form 424B5 — May 22, 2026
Assembly Biosciences (ASMB) has priced a follow-on equity offering of 3,358,602 shares of common stock and 415,000 pre-funded warrants at $26.50 per share, raising approximately $93.3 million in net proceeds. The offering is underwritten by Guggenheim Securities and UBS Investment Bank, with Mizuho and H.C. Wainwright also participating. The company plans to use the proceeds to fund the clinical development of its pipeline candidates, including ABI-6250, and for general corporate purposes.
Key figures
- Net Proceeds
- 93300000
- Cash Position
- 198600000
- Gross Proceeds
- 100000038
- Offering Price
- 26.5
- Shares Offered
- 3358602
- Shares Outstanding
- 15892353
- Lockup Period Days
- 90
- Pre Funded Warrants Offered
- 415000
- Underwriters Option Shares
- 566040
- Net Tangible Book Value Per Share
- 12.5
- Pre Funded Warrant Exercise Price
- 0.001
- Dilution Per Share To New Investors
- 11.34
- Adjusted Net Tangible Book Value Per Share
- 15.16
Price after filing
Close on the filing date to close N calendar days later (from $26.50). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.